The core earnings decline (adjusted earnings less notable items down 18% YoY) and the pending merger uncertainty are the key themes. Watch for updates on the Aquarian Capital merger regulatory approvals and any extension of the December 6 outside date, as deal completion risk is elevated.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $42.60entry
- T+1 · 8d ago +3.26%α +0.90% · $43.99
- T+5 · 4d ago +3.03%α +0.43% · $43.89
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Brighthouse Financial reported Q3 2026 net income available to shareholders of $302M ($5.21 per share), down from $453M ($7.89 per share) in Q3 2025. Adjusted earnings, less notable items, were $213M ($3.68 per share), compared to $261M ($4.54 per share) a year ago. The GAAP annual actuarial review contributed a net favorable $278M to net income. The pending merger with Aquarian Capital at $70/share faces regulatory delays, with the outside date extended to December 6, 2026 and further extension discussions underway.
Key Financial Metrics
Key Facts
- Net income available to shareholders: $302M ($5.21/diluted share) vs $453M ($7.89) in Q3 2025
- Adjusted earnings, less notable items: $213M ($3.68/share) vs $261M ($4.54) YoY
- GAAP annual actuarial review added $278M net favorable to net income
- Adjusted earnings: $527M ($9.12/share) vs $970M ($16.87) YoY, with $314M in favorable notable items
- Annuity sales $2.4B, down 12% YoY; Life sales $36M, down 5% YoY
- Combined RBC ratio 415%-435%, within target range of 400%-450%
- Holding company liquid assets $1.0B
- Pending merger with Aquarian Capital at $70/share; regulatory approvals not expected by Dec 6, 2026 outside date; discussions to extend underway
Financial Impact
Adjusted earnings, less notable items, declined 18% YoY to $213M; net income available to shareholders fell 33% YoY to $302M
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Annuities | $1.3B | -0.2% |
| Life | $268.0M | -9.8% |
| Run-off | $366.0M | -4.9% |
| Corporate Other | $137.0M | -10.5% |
Risk Factors
- Merger with Aquarian Capital may not close by Dec 6, 2026 outside date; regulatory approvals in DE, NY, MA not expected in time
- Core adjusted earnings (less notable items) declining YoY, driven by lower annuity and life sales and reduced net investment income
- Statutory combined total adjusted capital declining sequentially ($4.8B vs $4.9B in Q2 2026 and $5.4B in Q3 2025)
- Significant GAAP earnings volatility from market risk benefits and derivative gains/losses
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001685040-26-000035 |
| Document: q32026bhfearningspressrele.htm | 0001685040-26-000035 |
| Document: bhf-20261105.htm | 0001685040-26-000035 |
| Document: 0001685040-26-000035-index-headers.html | 0001685040-26-000035 |
| Document: 0001685040-26-000035-index.html | 0001685040-26-000035 |
| Document: 0001685040-26-000035.txt | 0001685040-26-000035 |
| 8-K Data (Synthetic) | 0001685040-26-000035 |
Track record
3 reports on BHF
Filters
- Nov 6, 202610d ago Institutional Cluster Mixed 3/10 Entry $42.60 to $43.89 Now $42.88 +0.66% ▲ +3.03% +0.43% vs SPY
- Nov 5, 202611d ago 8-K Bearish 5/10 Viewing Entry $42.60 to $43.89 Now $42.88 −0.66% ▼ −3.03% −0.43% vs SPY
- Sep 1, 202611w ago Court Ruling Neutral 1/10 Entry $53.62 to $50.84 Now $42.88 −20.03% ▼ −5.18% −4.23% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers